Taken together, genetic variations in TAS2R3/4 may contribute to alteration of the maturation and/or function of thyrocytes and the risk of developing papillary thyroid carcinoma [253]. This evidence concerns the gene TAS2R3 and differentiated thyroid carcinoma.